| scholarly article | Q13442814 |
| P50 | author | Alex J Sutton | Q124202084 |
| P2093 | author name string | Andrea Manca | |
| Pedro Saramago | |||
| P2860 | cites work | How should meta-regression analyses be undertaken and interpreted? | Q28193388 |
| Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study | Q28196342 | ||
| Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews | Q29619492 | ||
| Combination of direct and indirect evidence in mixed treatment comparisons | Q29619499 | ||
| Imputing missing standard deviations in meta-analyses can provide accurate results | Q29620610 | ||
| Meta-analysis of continuous outcome data from individual patients. | Q30657054 | ||
| Meta-analysis of ordinal outcomes using individual patient data. | Q30657056 | ||
| A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis | Q30669346 | ||
| Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head | Q30670986 | ||
| To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data | Q30676636 | ||
| Meta-analysis of data on costs from trials of counselling in primary care: using individual patient data to overcome sample size limitations in economic analyses | Q30801243 | ||
| Meta-analysis of a binary outcome using individual participant data and aggregate data | Q30968230 | ||
| An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes | Q31004727 | ||
| Improving ecological inference using individual-level data | Q31010622 | ||
| Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. | Q31016826 | ||
| Estimation of markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis, and model calibration | Q31017619 | ||
| A systematic review identifies a lack of standardization in methods for handling missing variance data | Q31034732 | ||
| Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods | Q31108600 | ||
| Meta-analysis of individual- and aggregate-level data. | Q31113276 | ||
| Meta-analysis of continuous outcomes combining individual patient data and aggregate data | Q31139467 | ||
| 'Lost in translation': accounting for between-country differences in the analysis of multinational cost-effectiveness data | Q33261643 | ||
| Meta-analysis of mixed treatment comparisons at multiple follow-up times | Q51922784 | ||
| Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies | Q52024329 | ||
| Borrowing strength from external trials in a meta-analysis | Q52287071 | ||
| A multilevel model framework for meta-analysis of clinical trials with binary outcomes | Q52927136 | ||
| A decision chart for assessing and improving the transferability of economic evaluation results between countries | Q53286025 | ||
| Comparing short form 6D, standard gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: results from total hip arthroplasty patients | Q53312432 | ||
| Resource costing for multinational neurologic clinical trials: methods and results | Q53349919 | ||
| Quality of life after spinal cord injury: a meta analysis of the effects of disablement components | Q53585520 | ||
| On the Mathematical Foundations of Theoretical Statistics | Q55868959 | ||
| Modelling the cost effectiveness of TNF- antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry | Q57751320 | ||
| Biologic drugs for rheumatoid arthritis in the medicare program: A cost-effectiveness analysis | Q57995685 | ||
| Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis | Q57995927 | ||
| Hierarchical related regression for combining aggregate and individual data in studies of socio-economic disease risk factors | Q60168197 | ||
| Models for potentially biased evidence in meta-analysis using empirically based priors | Q61853112 | ||
| Theoretical Foundation of Patient v. Population Preferences in Calculating QALYs | Q63185235 | ||
| Multi-state models and diabetic retinopathy | Q71179613 | ||
| Economics and the evaluation of health care programmes: generalisability of methods and implications for generalisability of results | Q73269317 | ||
| Network meta-analysis for indirect treatment comparisons | Q74720205 | ||
| The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial | Q79934872 | ||
| Establishing the cost-effectiveness of new pharmaceuticals under conditions of uncertainty--when is there sufficient evidence? | Q81037141 | ||
| A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpoint | Q81880574 | ||
| Modelling correlated clinical outcomes in health technology appraisal | Q84939143 | ||
| Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study | Q33265015 | ||
| Meta-analysis of diagnostic test studies using individual patient data and aggregate data | Q33371870 | ||
| Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials | Q33414055 | ||
| Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE). | Q33438708 | ||
| Indirect estimation of a discrete-state discrete-time model using secondary data analysis of regression data | Q33448660 | ||
| Practical approach for using Medicare data to estimate costs for cost-effectiveness analysis | Q33508902 | ||
| EuroQol: the current state of play | Q33571065 | ||
| Cost-utility of the cochlear implant in adults: a meta-analysis | Q33771179 | ||
| Summarising economic evaluations in systematic reviews: a new approach | Q33806093 | ||
| One thousand health-related quality-of-life estimates | Q33937445 | ||
| Modelling publication bias in meta-analysis: a review | Q34146621 | ||
| Use of Secondary Data to Estimate Instantaneous Model Parameters of Diabetic Heart Disease: Lemonade Method | Q34259583 | ||
| The utility of health states after stroke: a systematic review of the literature | Q34270390 | ||
| Meta-analysis of the literature or of individual patient data: is there a difference? | Q34334544 | ||
| Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals | Q34420746 | ||
| A meta-analysis of quality-of-life estimates for stroke | Q35056737 | ||
| Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people | Q35185667 | ||
| Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. | Q35580517 | ||
| Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach | Q35674633 | ||
| Generalisability in economic evaluation studies in healthcare: a review and case studies. | Q35950554 | ||
| Challenges in systematic reviews of economic analyses | Q36169168 | ||
| Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997. | Q36301651 | ||
| Meta-analysis of heterogeneously reported trials assessing change from baseline | Q36327922 | ||
| Evidence synthesis, parameter correlation and probabilistic sensitivity analysis | Q36359124 | ||
| Bayesian methods for evidence synthesis in cost-effectiveness analysis | Q36381197 | ||
| Assessing generalisability in model-based economic evaluation studies: a structured review in osteoporosis | Q36439111 | ||
| Preference-Based EQ-5D index scores for chronic conditions in the United States | Q36541277 | ||
| Analysis sans frontières: can we ever make economic evaluations generalisable across jurisdictions? | Q36635503 | ||
| Etanercept and efalizumab for the treatment of psoriasis: a systematic review | Q36644125 | ||
| A comparison of meta-analytic results using literature vs individual patient data. Paternal cell immunization for recurrent miscarriage | Q36691413 | ||
| Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group | Q36790212 | ||
| A review and meta-analysis of prostate cancer utilities. | Q36821787 | ||
| Recent developments in meta-analysis. | Q36859537 | ||
| Ecologic studies revisited | Q36960128 | ||
| Evaluation of networks of randomized trials | Q36966424 | ||
| Health-state utilities in liver disease: a systematic review. | Q37142994 | ||
| Bias modelling in evidence synthesis | Q37154328 | ||
| Use of indirect and mixed treatment comparisons for technology assessment | Q37259556 | ||
| A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered | Q37373846 | ||
| Predictive model for progression of hearing loss: meta-analysis of multi-state outcome. | Q37400227 | ||
| An updated systematic review of Health State Utility Values for osteoporosis related conditions | Q37409263 | ||
| Systematic reviews of economic evaluations: utility or futility? | Q37451168 | ||
| The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report | Q37594899 | ||
| Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region | Q37627235 | ||
| Checking consistency in mixed treatment comparison meta-analysis | Q37705195 | ||
| Study designs to detect sponsorship and other biases in systematic reviews | Q37740324 | ||
| A review and meta-analysis of utility values for lung cancer | Q37744304 | ||
| A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure. | Q37759327 | ||
| Health-state utility values in breast cancer. | Q37800481 | ||
| The ecological fallacy | Q39636510 | ||
| Use of evidence in economic decision models: practical issues and methodological challenges | Q40151124 | ||
| Whither trial-based economic evaluation for health care decision making? | Q40349299 | ||
| The interpretation of random-effects meta-analysis in decision models. | Q40373458 | ||
| Mixed treatment comparison with multiple outcomes reported inconsistently across trials: evaluation of antivirals for treatment of influenza A and B. | Q40412810 | ||
| Short-term cost effectiveness and long-term cost analysis comparing laparoscopic Nissen fundoplication with proton-pump inhibitor maintenance for gastro-oesophageal reflux disease. | Q40428039 | ||
| Meta-analytic tools for medical decision making: a practical guide | Q40616355 | ||
| The estimation of a preference-based measure of health from the SF-36. | Q40647897 | ||
| Hierarchical models in generalized synthesis of evidence: an example based on studies of breast cancer screening | Q40734392 | ||
| Modelling the long-term cost-effectiveness of endovascular or open repair for abdominal aortic aneurysm | Q42631874 | ||
| Efficacy of rivastigmine in Alzheimer's disease patients with rapid disease progression: results of a meta-analysis | Q42664556 | ||
| Correlations between parameters in risk models: estimation and propagation of uncertainty by Markov Chain Monte Carlo | Q43368497 | ||
| Cost-effectiveness analysis: discount the placebo at your peril | Q44070364 | ||
| Populating an economic model with health state utility values: moving toward better practice | Q45125267 | ||
| The Quality of Well-Being Scale: critical similarities and differences with SF-36. | Q46000316 | ||
| A meta-analysis of utility estimates for HIV/AIDS. | Q46061609 | ||
| Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling | Q47345641 | ||
| A chain of evidence with mixed comparisons: models for multi-parameter synthesis and consistency of evidence | Q47626233 | ||
| Variation in the estimation of quality-adjusted life-years by different preference-based instruments | Q47791282 | ||
| A discrete-state discrete-time model using indirect observation | Q48460608 | ||
| Evaluating novel agent effects in multiple-treatments meta-regression | Q50674589 | ||
| Quality of life in cardiac patient research: a meta-analysis | Q51032221 | ||
| Ecology. Nonlinearity and the Moran effect | Q51203692 | ||
| Assessing differences in utility scores: a comparison of four widely used preference-based instruments. | Q51745178 | ||
| Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation | Q51835764 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cost-effectiveness analysis | Q1754768 |
| economic model | Q2180497 | ||
| statistical model | Q3284399 | ||
| statistics | Q12483 | ||
| decision support techniques | Q69043532 | ||
| P304 | page(s) | 639-649 | |
| P577 | publication date | 2012-05-23 | |
| P1433 | published in | Value in Health | Q15766908 |
| P1476 | title | Deriving input parameters for cost-effectiveness modeling: taxonomy of data types and approaches to their statistical synthesis | |
| Deriving Input Parameters for Cost-Effectiveness Modeling: Taxonomy of Data Types and Approaches to Their Statistical Synthesis | |||
| P478 | volume | 15 |
| Q64901376 | A systematic review of decision analytic modeling techniques for the economic evaluation of dental caries interventions. |
| Q56333365 | Building a Decision Tree Cost Effectiveness Model |
| Q35532586 | Comparative efficiency research (COMER): meta-analysis of cost-effectiveness studies |
| Q99556704 | Comparison of risk-of-bias assessment approaches for selection of studies reporting prevalence for economic analyses |
| Q60908210 | Cost-Effectiveness Analysis of the Use of Point-of-Care C-Reactive Protein Testing to Reduce Antibiotic Prescribing in Primary Care |
| Q57302557 | Cost-effectiveness of screening forHLA-A*31:01prior to initiation of carbamazepine in epilepsy |
| Q40012702 | Cost-effectiveness of the Cardiac Component of the Focused Assessment of Sonography in Trauma Examination in Blunt Trauma |
| Q59808171 | Decision modelling for economic evaluation of liver transplantation |
| Q39632327 | Determination of a Testing Threshold for Lumbar Puncture in the Diagnosis of Subarachnoid Hemorrhage after a Negative Head Computed Tomography: A Decision Analysis |
| Q38737063 | Establishing benchmark EQ-5D-3L population health state utilities and identifying their correlates in Gansu Province, China |
| Q92894198 | Health Utility Book (HUB)-Cancer: Protocol for a Systematic Literature Review of Health State Utility Values in Cancer |
| Q50422429 | Health state utility values among children and adolescents with disabilities: protocol for a systematic review |
| Q27004266 | Health state utility values for diabetic retinopathy: protocol for a systematic review and meta-analysis |
| Q99554825 | Linked Pharmacometric-Pharmacoeconomic Modelling and Simulation in Clinical Drug Development |
| Q31135481 | Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain. |
| Q30823226 | Methods to construct a step-by-step beginner's guide to decision analytic cost-effectiveness modeling |
| Q30850451 | Network meta-analysis of (individual patient) time to event data alongside (aggregate) count data |
| Q87035432 | Output correlations in probabilistic models with multiple alternatives |
| Q37280123 | Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis |
| Q38129122 | Reviewing the Evidence to Inform the Population of Cost-Effectiveness Models within Health Technology Assessments |
| Q38103515 | Squinting Through Layers of Fog: Assessing the Cost Effectiveness of Treatments for Multiple Sclerosis |
| Q40052751 | Using environmental engineering to increase hand hygiene compliance: a cross-over study protocol. |
Search more.